J. Tabernero Et Al. , "Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS," GASTRIC CANCER , vol.23, no.4, pp.689-698, 2020
Tabernero, J. Et Al. 2020. Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS. GASTRIC CANCER , vol.23, no.4 , 689-698.
Tabernero, J., Alsina, M., Shitara, K., Doi, T., Dvorkin, M., Mansoor, W., ... Arkenau, H.(2020). Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS. GASTRIC CANCER , vol.23, no.4, 689-698.
Tabernero, Josep Et Al. "Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS," GASTRIC CANCER , vol.23, no.4, 689-698, 2020
Tabernero, Josep Et Al. "Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS." GASTRIC CANCER , vol.23, no.4, pp.689-698, 2020
Tabernero, J. Et Al. (2020) . "Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS." GASTRIC CANCER , vol.23, no.4, pp.689-698.
@article{article, author={Josep Tabernero Et Al. }, title={Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS}, journal={GASTRIC CANCER}, year=2020, pages={689-698} }